Immuno-Biological Laboratories Co (TSE:4570) Beneish M-Score: -2.49 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4570 Immuno-Biological Laboratories Co Ltd TSE:4570
61 GF Score
Price 円994.00
GF Value 円578.92
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Immuno-Biological Laboratories Co Beneish M-Score?

Immuno-Biological Laboratories Co TSE:4570 -0.60% 61 Beneish M-Score is -2.49 as of Jul. 14, 2026. GuruFocus rates TSE:4570 with a GF Score™ of 61/100 and a GF Value™ of 円578.92 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 825 Biotechnology companies, Immuno-Biological Laboratories Co ranks better than 54.91% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.49 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Immuno-Biological Laboratories Co's Beneish M-Score or its related term are showing as below:

TSE:4570' s Beneish M-Score Range Over the Past 10 Years
Min: -6.3   Med: -2.53   Max: -1.39
Current: -2.49

During the past 13 years, the highest Beneish M-Score of Immuno-Biological Laboratories Co was -1.39. The lowest was -6.30. And the median was -2.53.


Immuno-Biological Laboratories Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Immuno-Biological Laboratories Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuno-Biological Laboratories Co Beneish M-Score Chart

Immuno-Biological Laboratories Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.27 -3.75 -2.24 -2.16 -2.49

Immuno-Biological Laboratories Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.24 0.00 -2.16 0.00 -2.49

TSE:4570 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuno-Biological Laboratories Co Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's Beneish M-Score falls into.


TSE:4570
61GF Score
Immuno-Biological Laboratories Co Ltd TSE:4570
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immuno-Biological Laboratories Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Immuno-Biological Laboratories Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7444+0.528 * 0.9302+0.404 * 1.2079+0.892 * 1.0366+0.115 * 0.9332
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8324+4.679 * 0.012956-0.327 * 0.7979
=-2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was 円179 Mil.
Revenue was 円1,005 Mil.
Gross Profit was 円707 Mil.
Total Current Assets was 円1,570 Mil.
Total Assets was 円2,155 Mil.
Property, Plant and Equipment(Net PPE) was 円213 Mil.
Depreciation, Depletion and Amortization(DDA) was 円19 Mil.
Selling, General, & Admin. Expense(SGA) was 円8 Mil.
Total Current Liabilities was 円276 Mil.
Long-Term Debt & Capital Lease Obligation was 円19 Mil.
Net Income was 円329 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円301 Mil.
Total Receivables was 円232 Mil.
Revenue was 円970 Mil.
Gross Profit was 円634 Mil.
Total Current Assets was 円1,390 Mil.
Total Assets was 円1,845 Mil.
Property, Plant and Equipment(Net PPE) was 円191 Mil.
Depreciation, Depletion and Amortization(DDA) was 円15 Mil.
Selling, General, & Admin. Expense(SGA) was 円9 Mil.
Total Current Liabilities was 円281 Mil.
Long-Term Debt & Capital Lease Obligation was 円35 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(178.667 / 1004.987) / (231.534 / 969.533)
=0.17778 / 0.23881
=0.7444

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(634.461 / 969.533) / (707.012 / 1004.987)
=0.654399 / 0.703504
=0.9302

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1569.646 + 213.171) / 2155.121) / (1 - (1390.318 + 191.148) / 1845.39)
=0.172753 / 0.143018
=1.2079

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1004.987 / 969.533
=1.0366

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(15.427 / (15.427 + 191.148)) / (18.543 / (18.543 + 213.171))
=0.07468 / 0.080025
=0.9332

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7.919 / 1004.987) / (9.179 / 969.533)
=0.00788 / 0.009467
=0.8324

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((18.674 + 276.194) / 2155.121) / ((35.091 + 281.335) / 1845.39)
=0.136822 / 0.171468
=0.7979

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(329.015 - 0 - 301.093) / 2155.121
=0.012956

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Immuno-Biological Laboratories Co has a M-score of -2.49 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.49 mean?
Immuno-Biological Laboratories Co (TSE:4570) has a Beneish M-Score of -2.49 as of Jul. 14, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Immuno-Biological Laboratories Co and its competitors. According to the industry distribution chart, Immuno-Biological Laboratories Co ranks #372 out of 825 companies in the Biotechnology industry, placing it in the top 45.1%.
Is Immuno-Biological Laboratories Co's Beneish M-Score too high?
Immuno-Biological Laboratories Co's current Beneish M-Score is -2.49. Based on the distribution chart, Immuno-Biological Laboratories Co ranks #372 out of 825 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Immuno-Biological Laboratories Co has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Immuno-Biological Laboratories Co's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Immuno-Biological Laboratories Co ranks #372 out of 825 companies for Beneish M-Score. This puts Immuno-Biological Laboratories Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Immuno-Biological Laboratories Co and its competitors. Immuno-Biological Laboratories Co's current Beneish M-Score is -2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuno-Biological Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co (TSE:4570) is currently considered Significantly Overvalued. The stock's GF Value™ is 円578.92, compared to a current price of 円994.00 — trading 71.7% above its estimated fair value. The current Beneish M-Score is -2.49. Immuno-Biological Laboratories Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Immuno-Biological Laboratories Co (TSE:4570), the current Beneish M-Score is -2.49 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immuno-Biological Laboratories Co (TSE:4570) Overvalued in 2026?

Based on GuruFocus' analysis, Immuno-Biological Laboratories Co stock appears to be overvalued. The current stock price of 円994.00 is trading 71.7% above its estimated GF Value™ of 円578.92. GuruFocus considers Immuno-Biological Laboratories Co to be Significantly Overvalued.

Key valuation signals for TSE:4570:

  • Beneish M-Score: -2.49
  • GF Value™: 円578.92 vs. price of 円994.00 (71.7% above fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the TSE:4570 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Immuno-Biological Laboratories Co Business Description

Address 1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
61GF Score

Get the complete analysis for TSE:4570

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円994.00
Price
円578.92
GF Value